Cargando…
Plasma Xanthine Oxidoreductase (XOR) Activity in Cardiovascular Disease Outpatients
Background: The mechanisms of the increased plasma xanthine oxidoreductase (XOR) activity in outpatients with cardiovascular disease were unclear. Methods and Results: A total of 372 outpatients were screened, and 301 outpatients with cardiovascular disease were prospectively analyzed. Blood samples...
Autores principales: | Matsushita, Masato, Shirakabe, Akihiro, Okazaki, Hirotake, Shibata, Yusaku, Goda, Hiroki, Shigihara, Shota, Asano, Kazuhiro, Tani, Kenichi, Kiuchi, Kazutaka, Murase, Takayo, Nakamura, Takashi, Takayasu, Tsutomu, Asano, Miwako, Okajima, Fumitaka, Kobayashi, Nobuaki, Hata, Noritake, Asai, Kuniya, Shimizu, Wataru |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
The Japanese Circulation Society
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7929762/ https://www.ncbi.nlm.nih.gov/pubmed/33693215 http://dx.doi.org/10.1253/circrep.CR-19-0116 |
Ejemplares similares
-
Plasma xanthine oxidoreductase activity in patients with decompensated acute heart failure requiring intensive care
por: Okazaki, Hirotake, et al.
Publicado: (2019) -
Time‐dependent changes in plasma xanthine oxidoreductase during hospitalization of acute heart failure
por: Okazaki, Hirotake, et al.
Publicado: (2020) -
Prognostic Value of Both Plasma Volume Status and Nutritional Status in Patients With Severely Decompensated Acute Heart Failure
por: Shirakabe, Akihiro, et al.
Publicado: (2019) -
Clinical Approach to Shortening Length of Hospital Stay in Elderly Patients With Acute Heart Failure Requiring Intensive Care
por: Shirakabe, Akihiro, et al.
Publicado: (2020) -
Hyperuricemia-Related Diseases and Xanthine Oxidoreductase (XOR) Inhibitors: An Overview
por: Chen, Changyi, et al.
Publicado: (2016)